Showing results (341-350 of 524) with videos related to

Sort By:
Pageof 53
International Journal of Cardiology|December 3, 2005
Should we perform an echocardiogram in hypertensive patients classified as having low and medium risk?Carmen Suárez, José Villar, Nieves Martel, et al.
Journal of Hypertension|June 12, 2009
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertensionAlberto Zanchetti, Giuseppe Mancia, Henry R Black, et al.
JACC. Advances|February 28, 2025
Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITYAjay K Singh, Glen James, Stefan D Anker, et al.
Diabetes Care|December 27, 2023
Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin ResistanceThomas Ebert, Stefan D Anker, Luis M Ruilope, et al.
Hypertension (Dallas, Tex. : 1979)|September 6, 2012
Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based studyJosé R Banegas, Auxiliadora Graciani, Juan J de la Cruz-Troca, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care StudyAntonio Rodríguez-Miguel, Beatriz Fernández-Fernández, Alberto Ortiz, et al.
American Journal of Physiology. Renal Physiology|February 1, 2007
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4Anna Solini, Eleonora Santini, Daniele Chimenti, et al.
Diabetes, Obesity & Metabolism|July 2, 2025
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney diseaseGian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.
Diabetes, Obesity & Metabolism|September 24, 2025
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world dataGian Paolo Fadini, Enrico Longato, Sara Poletto, et al.
Scientific Reports|January 22, 2020
miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic PotentialClaudia Cavallari, Federico Figliolini, Marta Tapparo, et al.
Pageof 53